Citigroup Inc Treace Medical Concepts, Inc. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Citigroup Inc holds 5,872 shares of TMCI stock, worth $17,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,872
Previous 17,508
66.46%
Holding current value
$17,792
Previous $102,000
61.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TMCI
# of Institutions
117Shares Held
58.1MCall Options Held
0Put Options Held
0-
Cibc Bancorp Usa Inc. Chicago, IL18.2MShares$55.2 Million0.15% of portfolio
-
Armistice Capital, LLC New York, NY6.32MShares$19.1 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$12.3 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.63MShares$11 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$8.28 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $168M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...